Home › Gallbladder Cancer › Ohio › Cleveland
Gallbladder Cancer clinical trials in Cleveland, OH
3 studies for Gallbladder Cancer are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
- Cleveland Clinic - Oncology Department, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
RecruitingPhase 3
- University Hospitals Cleveland Medical Center Seidman Cancer Center (Site 111), Cleveland
About Gallbladder Cancer
Gallbladder cancer is difficult to diagnose because there are no symptoms in its early stages. Read about tests, treatment options and prognosis.
More about Gallbladder Cancer on MedlinePlus
Gallbladder Cancer trials in other cities
- Nashville, TN5 studies
- Baldwin Park, CA4 studies
- Houston, TX4 studies
- Boston, MA4 studies
- Dallas, TX3 studies
- Oklahoma City, OK3 studies
- New York City, NY3 studies
- Seattle, WA3 studies
- Louisville, KY3 studies
- Los Angeles, CA3 studies
- Pittsburgh, PA3 studies
- Birmingham, AL3 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Heart Failure31 studies
- Metastatic Cancer30 studies
- Prostate Cancer30 studies
- Ovarian Cancer29 studies
- Lung Cancer26 studies
- Colorectal Cancer25 studies
- Acute Myeloid Leukemia20 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Cardiovascular Disease20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.